From: A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma
Variables | Overall |
---|---|
N | 156 |
Sex | |
Female | 43 (27.6) |
Male | 113 (72.4) |
Age (years) | |
≤ 65 | 52 (33.8) |
> 65 | 102 (66.2) |
Signet ring | |
No | 150 (96.2) |
Yes | 6 ( 3.8) |
T stage | |
1 | 14 ( 9.0) |
2 | 36 (23.1) |
3 | 52 (33.3) |
4a | 39 (25.0) |
4b | 15 ( 9.6) |
N stage | |
0 | 44 (28.2) |
1 | 27 (17.3) |
2 | 33 (21.2) |
3a | 31 (19.9) |
3b | 21 (13.5) |
Lauren | |
Diffuse | 31 (19.9) |
Intestinal | 93 (59.6) |
Not specified | 32 (20.5) |
Number of positive lymph nodes | 7.15 ± 10.11 |
Stage by AJCC 8th | |
Earlier stage (≤ IIa) | 44 (28.2) |
Later stage (> IIa) | 112 (71.8) |